Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4588)
All Articles published online
|
Dec 28, 2009 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Dong J, Yu XF, Zou J. Azithromycin-containing |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i48/6102.htm |
| Number | Citing Articles |
| 1 |
Tai‐Cherng Liou, Po‐Hao Liao, Yu‐Chun Lin, Cheng‐Hsin Chu, Shou‐Chuan Shih. Intraluminal therapy for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2019; 34(8): 1337 doi: 10.1111/jgh.14627
|
| 2 |
David Y. Graham. Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results. Clinical Gastroenterology and Hepatology 2010; 8(12): 1032 doi: 10.1016/j.cgh.2010.07.002
|
| 3 |
Mohammad Reza Esmaeili-Dooki, Hossein Shirdel, Mahmood Hajiahmadi. Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin. Iranian Journal of Pediatrics 2015; 25(6) doi: 10.5812/ijp.2360
|
| 4 |
Ariolana A dos Santos, Adriana A Carvalho. Pharmacological therapy used in the elimination of <italic>Helicobacter pylori</italic> infection: A review. World Journal of Gastroenterology 2015; 21(1): 139-154 doi: 10.3748/wjg.v21.i1.139
|
| 5 |
Yiqiao Xin, Jan Manson, Lindsay Govan, Robin Harbour, Jenny Bennison, Eleanor Watson, Olivia Wu. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0491-7
|
| 6 |
M. Escobedo-Belloc, F. Bosques-Padilla. The rise of antibiotic resistance to Helicobacter pylori in Mexico: Is azithromycin plus levofloxacin the answer?. Revista de Gastroenterología de México (English Edition) 2019; 84(3): 271 doi: 10.1016/j.rgmxen.2018.10.006
|
| 7 |
Ling Ren, Hong Lu, Hai Yan Li, Ling Yin Zhu, Xiao Qing Xu, Li Yang Gu, Zhi Zheng Ge, Xiao Bo Li. New dual therapy for primary treatment of Helicobacter pylori infection: A prospective randomized study in Shanghai, China. Journal of Digestive Diseases 2014; 15(11): 622 doi: 10.1111/1751-2980.12186
|
| 8 |
M. Escobedo-Belloc, F. Bosques-Padilla. El incremento en la resistencia de Helicobacter pylori a los antibióticos en México: ¿son la azitromicina más levofloxacina la respuesta?. Revista de Gastroenterología de México 2019; 84(3): 271 doi: 10.1016/j.rgmx.2018.10.005
|
| 9 |
Asma Nizam, Zao Iman Chaudary, Saad Ali Ahmad, Nimra Nawaz, Zainab Riaz, Aamir Shehzad, Muhammad Irfan Jamil. Comparison of the Efficacy of Two-Week Vonoprazan Versus Lansoprazole-Based Quadruple Sequential Antibiotic Therapy in Eradicating Helicobacter pylori Infection: A Non-randomized Clinical Trial. Cureus 2024; doi: 10.7759/cureus.52758
|
| 10 |
|
| 11 |
Seung Won Ra, Marc A. Sze, Eun Chong Lee, Sheena Tam, Yeni Oh, Nick Fishbane, Gerard J. Criner, Prescott G. Woodruff, Stephen C. Lazarus, Richard Albert, John E. Connett, Meilan K. Han, Fernando J. Martinez, Shawn D. Aaron, Robert M. Reed, S. F. Paul Man, Don D. Sin. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
. Respiratory Research 2017; 18(1) doi: 10.1186/s12931-017-0594-x
|